Pulmotect, Inc.
  • Home
  • About Us
    • Our Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Our Approach
    • Overview
    • Our Science
    • Our Pipeline
    • Published Journal Articles
  • News
  • Contact Us

Pulmotect Completes Second Clinical Trial, Obtains Funding

Posted on April 1, 2016April 1, 2017 by admin
Posted in News Coverage

Post navigation

Synthetic inhaled drug prevents pneumonia in cancer patients
Tour of Texas: Surge Ventures, Dell, Fannin Innovation, CellRight
Pulmotect Inc

3900 Essex Ln, Suite 575
Houston, TX 77027
Contact Us

© 2023
Pulmotect, Inc.